COVID-19 Vaccination and Glomerulonephritis

INTRODUCTION: mRNA COVID-19 vaccine is more effective than traditional vaccines owing to superior immune activation. Nevertheless, the impact of mRNA COVID-19 vaccine on triggering de novo/relapsing glomerulonephritis (GN) is limited. We report a case series of patients who developed new or relapsin...

Descripción completa

Detalles Bibliográficos
Autores principales: Klomjit, Nattawat, Alexander, Mariam Priya, Fervenza, Fernando C., Zoghby, Ziad, Garg, Arvind, Hogan, Marie C., Nasr, Samih H., Minshar, Marwan Abu, Zand, Ladan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493782/
https://www.ncbi.nlm.nih.gov/pubmed/34632166
http://dx.doi.org/10.1016/j.ekir.2021.09.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493782/
https://www.ncbi.nlm.nih.gov/pubmed/34632166
http://dx.doi.org/10.1016/j.ekir.2021.09.008

Ejemplares similares